BAY-069

N/A

Report date: 2022/10/20 14:49:45

NME

Base Information

Drug NameBAY-069

Drug Alias NameBAY-069

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBranched-chain-amino-acid aminotransferase, cytosolic inhibitorsBranched-chain-amino-acid aminotransferase, mitochondrial inhibitors

TargetsBranched-chain-amino-acid aminotransferase, cytosolicBranched-chain-amino-acid aminotransferase, mitochondrial

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBayer Pharma Ag

China Registration ClassN/A

Develop Information

Active CompaniesBayer Pharma Ag

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A